LENZ Therapeutics, Inc. (LENZ) Dividend History
Income profile from 2024 to 2025 with payout safety and yield-on-cost trend
LENZ Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
LENZ Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
LENZ Income Growth Story
Dividend per share and yield on cost over time (1 years of payments)
LENZ Dividend Safety Story
EPS is the container — dividend is what's drawn out
Dividend Analysis
Payout Safety
LENZ Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 5/9 — moderate financial health.
Growth Track Record
LENZ does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, LENZ returns capital through share repurchases. The combined picture: 0.3% buyback yield, 0.3% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -72.4%, with dividends contributing 16.5% of that performance.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $2,757 today.
LENZ Recent Dividend Payments
Last 2 payments · Semi-Annual
| Ex-Date | Amount | Change | Yield % | Payment Date |
|---|---|---|---|---|
| Mar 22, 2024Latest | $7.2100 | — | 89.01% | — |
| Mar 15, 2024 | $7.2100 | — | 45.60% | — |
LENZ Annual Dividend History (2019–2025)
7 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | -100.0% | 0 | $-2.85 | — | — | — |
| 2024 | $14.42 | — | 2 | $-2.34 | — | — | 16.5% |
| 2023 | $0.00 | — | 0 | $-15.30 | — | — | — |
| 2022 | $0.00 | — | 0 | $-12.89 | — | — | — |
| 2021 | $0.00 | — | 0 | $-8.54 | — | — | — |
| 2020 | $0.00 | — | 0 | $-8.24 | — | — | — |
| 2019 | $0.00 | — | 0 | $-0.01 | — | — | — |
See LENZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LENZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LENZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLENZ — Frequently Asked Questions
Quick answers to the most common questions about buying LENZ stock.
How much dividend does LENZ pay per share?
LENZ Therapeutics, Inc. (LENZ) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made Semi-Annual.
When is LENZ's next ex-dividend date?
LENZ's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. LENZ typically pays dividends Semi-Annual.
Is LENZ's dividend safe?
LENZ's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has LENZ increased its dividend?
LENZ has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does LENZ pay dividends?
LENZ Therapeutics, Inc. pays dividends Semi-Annual. The trailing 12-month total is N/A per share. Dividend data on this page covers 1+ years from 2024 to 2025.
How much would $10,000 invested in LENZ grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in LENZ five years ago would be worth approximately $2,757 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is LENZ's yield on cost for long-term holders?
LENZ's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.